Federal contract award
15B20526P00000021
TRADE NAME: UPTRAVI 600MCG TAB VA CLASS: CARDIOVASCULAR AGENTS, OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC DEVENS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $22.7K |
| Current contract value | $22.7K |
| Potential contract value / ceiling | $22.7K |
| Start date | Nov 24, 2025 |
| Current end date | Nov 24, 2025 |
| Potential end date | Nov 24, 2025 |
| Latest award activity | Dec 10, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 10, 2025 | P00001 | $22.7K | TRADE NAME: UPTRAVI 600MCG TAB VA CLASS: CARDIOVASCULAR AGENTS, OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE |
| Nov 24, 2025 | 0 | $0 | TRADE NAME: UPTRAVI 600MCG TAB VA CLASS: CARDIOVASCULAR AGENTS, OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.